Cel-Sci
CVM
#9810
Rank
ยฃ35.73 M
Marketcap
ยฃ4.47
Share price
-5.66%
Change (1 day)
-71.05%
Change (1 year)

Earnings for Cel-Sci (CVM)

Earnings in 2025 (TTM): -ยฃ18.89 Million

According to Cel-Sci 's latest financial reports the company's current earnings are N/A. In 2024 the company made an earning of -ยฃ19.8 Million, an increase over its 2023 earnings that were of -ยฃ22.61 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cel-Sci from 1986 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) -ยฃ18.89 Million-4.6%
2024 -ยฃ19.8 Million-12.41%
2023 -ยฃ22.61 Million-12.87%
2022 -ยฃ25.95 Million-3.42%
2021 -ยฃ26.87 Million13.44%
2020 -ยฃ23.68 Million11.28%
2019 -ยฃ21.28 Million179.81%
2018 -ยฃ7.61 Million-48.72%
2017 -ยฃ14.83 Million-16.23%
2016 -ยฃ17.71 Million-23.63%
2015 -ยฃ23.19 Million-5.47%
2014 -ยฃ24.53 Million198.49%
2013 -ยฃ8.22 Million
2010 -ยฃ9.59 Million
2004 -ยฃ3.25 Million12.38%
2003 -ยฃ2.89 Million-16.59%
2002 -ยฃ3.46 Million-59.28%
2001 -ยฃ8.49 Million23.17%
2000 -ยฃ6.9 Million20.12%
1999 -ยฃ5.74 Million13.24%
1998 -ยฃ5.07 Million-20%
1997 -ยฃ6.34 Million46.55%
1996 -ยฃ4.33 Million34.88%
1995 -ยฃ3.21 Million2.38%
1994 -ยฃ3.13 Million68%
1993 -ยฃ1.87 Million78.57%
1992 -ยฃ1.05 Million180%
1991 -ยฃ0.38 Million25%
1990 -ยฃ0.3 Million-0%
1989 -ยฃ0.3 Million-71.43%
1988 -ยฃ1.05 Million-0%
1987 -ยฃ1.05 Million-46.15%
1986 -ยฃ1.94 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Curis
CRIS
-ยฃ24.27 Million 31.68%๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
-ยฃ4.94 Million-73.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
ยฃ6.14 B-33,443.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-ยฃ0.11 Billion 458.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
ยฃ1.32 B-7,266.95%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
ยฃ24.14 B-131,127.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
ยฃ0.12 B-768.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Eterna Therapeutics
ERNA
-ยฃ7.08 Million-61.62%๐Ÿ‡บ๐Ÿ‡ธ USA